---
document_datetime: 2023-09-21 20:27:09
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/pemazyre-epar-all-authorised-presentations_en.pdf
document_name: pemazyre-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1773731
conversion_datetime: 2025-12-30 10:20:54.753299
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number                                                                                        | (Invented)                                   | Strength                     | Pharmaceutical                     | Route of                                              | Immediate Packaging                                                                                                                                                                 | Pack size                                              |
|-------------------------------------------------------------------------------------------------------|----------------------------------------------|------------------------------|------------------------------------|-------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------|
|                                                                                                       | name                                         |                              | Form                               | Administration                                        |                                                                                                                                                                                     |                                                        |
| EU/1/21/1535/001 EU/1/21/1535/002 EU/1/21/1535/003 EU/1/21/1535/004 EU/1/21/1535/005 EU/1/21/1535/006 | Pemazyre Pemazyre Pemazyre Pemazyre Pemazyre | 4.5 mg 4.5 mg 9 mg 9 mg 13.5 | Tablet Tablet Tablet Tablet Tablet | Oral use Oral use Oral use Oral use Oral use Oral use | blister (Aclar/PVC/paper/Alu) blister (Aclar/PVC/paper/Alu) blister (Aclar/PVC/paper/Alu) blister (Aclar/PVC/paper/Alu) blister (Aclar/PVC/paper/Alu) blister (Aclar/PVC/paper/Alu) | 14 tablets 28 tablets 14 tablets 28 tablets 14 tablets |
|                                                                                                       |                                              | mg                           |                                    |                                                       |                                                                                                                                                                                     |                                                        |
|                                                                                                       | Pemazyre                                     | 13.5 mg                      | Tablet                             |                                                       |                                                                                                                                                                                     | 28 tablets                                             |